NKGen Biotech moving to OTC Markets, cancels 1-for-6 reverse stock split
NKGen Biotech (NKGN) announced that on March 3 it received notice that the Nasdaq Hearings Panel determined to delist the company’s common ...
Nasdaq8d
NKGen Biotech, Inc. Transitions to OTC Markets Following Nasdaq Delisting, Retaining Compliance with SEC Reporting Requirements
The Company intends to apply to trade on the OTCQX platform, the highest OTC tier, which requires ongoing compliance with SEC public reporting requirements. After initial trading on OTC Pink in a ...
Yahoo Finance8d
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
The Company intends to apply to trade on the OTCQX platform, the highest OTC tier, which requires ongoing compliance with SEC public reporting requirements. After initial trading on OTC Pink in a ...